Dr. Laura Catherine Bowman M.D.
Hematologist (Pediatric) | Pediatric Hematology-Oncology6255 Barfield Rd Ne Suite 175 Atlanta GA, 30328
Dr. Laura Bowman is a pediatric hematologist practicing in Atlanta, GA. Dr. Bowman specializes in treating children that have a blood disease or cancer. Such blood diseases include disorders of red blood cells, white blood cells and/or platelets. The types of cancers that Dr. Bowman treats include leukemias, lymphomas and certain tumors. Dr. Bowman can also treat bleeding disorders in children. Pediatric hematologists can be found in childrens hospitals, community hospitals, university medical centers and more.
Education and Training
Indiana University School of Medicine 1981
- Long-term outcome of patients with intraspinal neuroblastoma.
- Late effects in survivors of infant leukemia.
- Improved cerebrovascular patency following therapy in patients with sickle cell disease: initial results in 4 patients who received HLA-identical hematopoietic stem cell allografts.
- Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.
- Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.
- Allogeneic bone marrow transplantation for infants with acute leukemia or myelodysplastic syndrome.
- Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
- Energy expenditure in children undergoing hematopoietic stem cell transplantation.
- Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
- Local and systemic effects of an allogeneic tumor cell vaccine combining transgenic human lymphotactin with interleukin-2 in patients with advanced or refractory neuroblastoma.
- Occult orbital neuroblastoma detected after administration of an antitumor vaccine.
- Nephrotoxicity of iopamidol in pediatric, adolescent, and young adult patients who have undergone allogeneic bone marrow transplantation.
- Fibrolamellar hepatocellular carcinoma in children and adolescents.
- Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors.
- Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome.
- Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
- Early increase in osteoclast number in mice after whole-body irradiation with 2 Gy X rays.
- Childhood chondrosarcoma: MR imaging with gadolinium-DTPA.
- A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up.
- Peripheral primitive neuroectodermal tumor (peripheral neuroepithelioma) in children. A review of the St. Jude experience and controversies in diagnosis and management.
- Evaluation of the protective efficacy of Haemophilus influenzae type b vaccines in an animal model.
- A phase I study of sulofenur in refractory pediatric malignant solid tumors.
- Dental abnormalities in long-term survivors of head and neck rhabdomyosarcoma.
- Intrathoracic desmoid tumor: CT and MRI appearance.
- Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatin.
- Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells.
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors.
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in children with relapsed solid tumors.
- Management of pediatric liver tumors.
- Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia.
- Dental abnormalities in children treated for neuroblastoma.
- Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma.
- Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients.
- Algorithm for nutritional support: experience of the Metabolic and Infusion Support Service of St. Jude Children's Research Hospital.
Dr. Laura Catherine Bowman M.D.'s Practice location
Atlanta, GA 30328Get Direction
Dr. Laura Catherine Bowman M.D.'s reviewsWrite Review
Patient Experience with Dr. Bowman
- The Signs of Strep Throat
What is strep throat?Strep throat is the most common form of bacterial infection of the throat and tonsils, resulting in inflammation and irritation. Strep throat is caused by different types of streptococcus bacteria. The severity of the condition differs from one type of bacteria to another. Not...
- 1 Week Pregnant
IntroductionWomen who are not planning a pregnancy may not realize they are pregnant on week one. Some may not even know it even after week two. The reason is that there are a lot of variables when it comes to women’s monthly cycles, so most women tend to assume that they only have a late...
PurpuraPurpura refers to purple-colored spots that are usually seen on the skin, including mucous membranes and other organs. It is also called skin hemorrhages or blood spots.Purpura is usually recognized when there is pooling of blood under the skin due to ruptured small blood vessels. The size of...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- How Is Leukemia Diagnosed?
Leukemia in its early stages may present no signs or symptoms, as these only appear when the leukemia cells have taken over a large number of normal blood cells. A person with leukemia is very lucky indeed if early-stage detection occurs incidentally, through a routine blood test or one done for...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- Dr. Karen Elizabeth Effinger MD, MS300 Pasteur Dr Stanford CA 94305
- Dr. Iris Buchanan MD75 Piedmont Ave Atlanta GA 30303
- Dr. Elna Njuikwo Saah M.D.1200 E Michigan Ave Lansing MI 48912
- Dr. Amy L Dunn MD5455 Meridian Mark Rd Ne Atlanta GA 30342
- Dr. Tanya Carens Watt M.D.1405 Clifton Rd Ne Atlanta GA 30322
- Dr. Carolyn M Bennett MD5455 Meridian Marks Rd Ne Atlanta GA 30342